Hlk Biotech Holding Stock Net Income
| AMHD Stock | USD 0.0002 0.00 0.00% |
HLK Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
HLK Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing HLK Biotech's valuation are provided below:HLK Biotech Holding does not today have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. HLK |
HLK Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HLK Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HLK Biotech.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in HLK Biotech on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding HLK Biotech Holding or generate 0.0% return on investment in HLK Biotech over 90 days. HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel More
HLK Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HLK Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HLK Biotech Holding upside and downside potential and time the market with a certain degree of confidence.
HLK Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HLK Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HLK Biotech's standard deviation. In reality, there are many statistical measures that can use HLK Biotech historical prices to predict the future HLK Biotech's volatility.HLK Biotech Holding Backtested Returns
We have found three technical indicators for HLK Biotech Holding, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and HLK Biotech are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
HLK Biotech Holding has perfect predictability. Overlapping area represents the amount of predictability between HLK Biotech time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HLK Biotech Holding price movement. The serial correlation of 1.0 indicates that 100.0% of current HLK Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, HLK Biotech Holding reported net income of (3,769). This is 100.0% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 100.0% higher than that of the company.
HLK Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HLK Biotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of HLK Biotech could also be used in its relative valuation, which is a method of valuing HLK Biotech by comparing valuation metrics of similar companies.HLK Biotech is currently under evaluation in net income category among its peers.
HLK Fundamentals
| Return On Asset | -0.97 | |||
| Revenue | 8.33 K | |||
| Gross Profit | (180 K) | |||
| EBITDA | (701.16 K) | |||
| Net Income | (3.77 K) | |||
| Cash And Equivalents | 185.72 K | |||
| Total Debt | 600 K | |||
| Current Ratio | 0.16 X | |||
| Cash Flow From Operations | (1.21 K) | |||
| Beta | 1.99 | |||
| Market Capitalization | 462.46 K | |||
| Total Asset | 116.71 K | |||
| Z Score | -19.8 | |||
| Net Asset | 116.71 K |
About HLK Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HLK Biotech Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HLK Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HLK Biotech Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in HLK Pink Sheet
HLK Biotech financial ratios help investors to determine whether HLK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLK with respect to the benefits of owning HLK Biotech security.